Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Cabozantinib> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Cabozantinib abstract "Cabozantinib (marketed under the tradename Cometriq, formerly known as XL184) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis.It was developed by Exelixis Inc. Cabozantinib was granted orphan drug status by the U.S. Food and Drug Administration (FDA) in January 2011.Cabozantinib was approved by the U.S. FDA in November 2012 for the treatment of medullary thyroid cancer. It is currently undergoing clinical trials for the treatment of prostate, bladder, ovarian, brain, melanoma, breast, non-small cell lung, pancreatic, hepatocellular and kidney cancers.".
- Cabozantinib atcPrefix "none".
- Cabozantinib casNumber "849217-68-1".
- Cabozantinib chEBI "72317".
- Cabozantinib fdaUniiCode "1C39JW444G".
- Cabozantinib iupacName "N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide".
- Cabozantinib thumbnail Cabozantinib.svg?width=300.
- Cabozantinib wikiPageExternalLink 270085-exelixis-looming-cancer-conference-a-favorable-swing-trade-opportunity.
- Cabozantinib wikiPageExternalLink Abstracts?&vmview=abst_detail_view&confID=65&abstractID=35249.
- Cabozantinib wikiPageID "31813863".
- Cabozantinib wikiPageRevisionID "600361784".
- Cabozantinib atcPrefix "none".
- Cabozantinib c "28".
- Cabozantinib casNumber "849217".
- Cabozantinib chebi "72317".
- Cabozantinib chemspiderid "25948202".
- Cabozantinib eliminationHalfLife "198000.0".
- Cabozantinib excretion "Faeces , urine".
- Cabozantinib f "1".
- Cabozantinib h "24".
- Cabozantinib hasPhotoCollection Cabozantinib.
- Cabozantinib iupacName "N--N-cyclopropane-1,1-dicarboxamide".
- Cabozantinib kegg "D10062".
- Cabozantinib legalUs "Rx-only".
- Cabozantinib licenceUs "Cabozantinib".
- Cabozantinib metabolism "Hepatic".
- Cabozantinib molecularWeight "501.51".
- Cabozantinib n "3".
- Cabozantinib o "5".
- Cabozantinib pregnancyUs "D".
- Cabozantinib proteinBound "≥99.7%".
- Cabozantinib routesOfAdministration "Oral".
- Cabozantinib smiles "O=CNC=CC=C3OC4=CC5=NC=C4".
- Cabozantinib stdinchi "1".
- Cabozantinib stdinchikey "ONIQOQHATWINJY-UHFFFAOYSA-N".
- Cabozantinib synonyms "XL184, BMS907351".
- Cabozantinib tradename "Cometriq".
- Cabozantinib unii "1".
- Cabozantinib subject Category:Cyclopropanes.
- Cabozantinib subject Category:Organofluorides.
- Cabozantinib subject Category:Quinolines.
- Cabozantinib subject Category:Tyrosine_kinase_inhibitors.
- Cabozantinib type Agent114778436.
- Cabozantinib type Anesthetic102710766.
- Cabozantinib type CausalAgent100007347.
- Cabozantinib type Cyclopropane103155661.
- Cabozantinib type Cyclopropanes.
- Cabozantinib type Drug103247620.
- Cabozantinib type GeneralAnesthetic103433434.
- Cabozantinib type InhalationAnesthetic103570838.
- Cabozantinib type Matter100020827.
- Cabozantinib type Medicine103740161.
- Cabozantinib type PhysicalEntity100001930.
- Cabozantinib type Substance100020090.
- Cabozantinib type TyrosineKinaseInhibitor104506005.
- Cabozantinib type TyrosineKinaseInhibitors.
- Cabozantinib type Drug.
- Cabozantinib type FunctionalSubstance.
- Cabozantinib comment "Cabozantinib (marketed under the tradename Cometriq, formerly known as XL184) is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and has been shown to reduce tumor growth, metastasis, and angiogenesis.It was developed by Exelixis Inc. Cabozantinib was granted orphan drug status by the U.S. Food and Drug Administration (FDA) in January 2011.Cabozantinib was approved by the U.S. FDA in November 2012 for the treatment of medullary thyroid cancer.".
- Cabozantinib label "Cabozantinib".
- Cabozantinib label "Cabozantinib".
- Cabozantinib sameAs Cabozantinib.
- Cabozantinib sameAs m.0gtvzpd.
- Cabozantinib sameAs Q795057.
- Cabozantinib sameAs Q795057.
- Cabozantinib sameAs Cabozantinib.
- Cabozantinib wasDerivedFrom Cabozantinib?oldid=600361784.
- Cabozantinib depiction Cabozantinib.svg.
- Cabozantinib isPrimaryTopicOf Cabozantinib.
